Last reviewed · How we verify

NCT07317973

A Study About Patient Decision Aids Designed to Help Parents and Guardians in Canada Make Evidence-informed, Values-congruent Decisions About Screening Children for Type 1 Diabetes and Follow-up Decisions.

Not yet recruiting NA Last updated 5 January 2026
What this trial tests

NA trial testing Web-based patient decision aid in Diabetes, Mellitus, Type 1 in 350 participants. Not yet recruiting.

Timeline
1 February 2026
Primary endpoint
31 January 2027
30 April 2028

Quick facts

Lead sponsorLaval University
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposescreening
Enrollment350
Start date1 February 2026
Primary completion31 January 2027
Estimated completion30 April 2028

Drugs / interventions tested

Conditions studied

Sponsor

Laval University

Who can join

18 and older, any sex, with Diabetes, Mellitus, Type 1. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will design and test patient decision aids to help parents and guardians in Canada make decisions about screening their children for type 1 diabetes. To do this, we will work with a panel of parents and guardians as well as scientific experts, show draft designs to parents and guardians, improve the draft designs based on feedback, and finally test the patient decision aids in online studies.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Web-based patient decision aid

Trials testing the same drug.

Other Laval University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07317973.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing